Press Releases
Dendritic Cell and CAR-T Therapies Market to Witness Steady Expansion During 2017 - 2025

, 13 June 2019 -- Dendritic Cell and CAR-T Therapies Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025

Dendritic cells are known as accessory cells of the mammalian immune system. Their major function is to process surface antigen of T cells of immune system. Chimeric Antigen Receptor (CAR-T) therapy is an immunotherapy, which is primarily used to treat cancers. Dendritic cells are antigen-presenting cells that are a part of mammalian cells and functions by provoking anti-tumor responses. Dendritic cells can be activated in vivo by genetic engineering. Current cellular immunotherapy treatment therapies are divided into CAR-T, CAR-NK, stem cell therapeutics direct reprogramming, and dendritic cell immunotherapies. Sipuleucel-T is the only approved immunotherapy based on the concept of dendritic cells mechanism, which was approved in 2010 for the treatment of metastatic prostate cancer. In August 2017, the U.S. food drug admiration (FDA) approved Kymriah CAR-T therapy for the treatment of acute lymphoblastic leukemia. In October 2017, Kite Pharma obtained FDA approval for its CAR-T cell therapy Yescarta. Kite Pharma was the second company to launch CAR-T in the market.

Obtain Report Details @

In last decade, there has been significant growth in in developed countries and awareness initiative taken by government to educate patients about early diagnostic test and treatment. This has helped in the early detection of cancer, which is preventing the disease from progressing into aggressive or advanced stages. This, in turn, is supporting the expansion of the cancer treatment market. Increasing prevalence of the disease, awareness regarding advancements in treatments and availability of various treatments drive market for cancer treatment market.

New and upcoming therapy options such as cancer immunotherapy are likely to propel the dendritic cell and CAR-T therapies market. High cost of cellular immunotherapy and availability of treatment only in developed countries are factors that are likely to restrain the dendritic cell and CAR-T therapies market. Recently launched CAR-T drug Kymriah by Swiss pharmaceutical giant Novartis AG is projected to boost the dendritic cell and CAR-T therapies market. Now a days cell therapy companies are vastly growing due to growing factors such as high number of cell therapy clinical trials, fasten cell therapy product approvals. Adoption of novel technologies for cell immunotherapy to transform healthcare.

Request Report Brochure @

The dendritic cell and CAR-T therapies market has been classified based on types of drugs, distribution channel, and geography. In terms of types of drugs, the market has been divided into drugs such as Kymriah (CAR-T therapy based), Sipuleucel-T (dendritic cell therapy based), and others. Based on type of distribution channel, the dendritic cell and CAR-T therapies market is bifurcated into hospitals and specialty clinics.

In terms of region the dendritic cell and CAR-T therapies market has been segmented into North America, Latin America, Europe, Middle East & Africa, and Asia Pacific. North America and Europe dominate the market. Rising prevalence of disease, world class diagnosis techniques, growing awareness among people, and increasing geriatric population are driving market in these regions. High investment in R&D activities and presence of African American population who are susceptible to cancer are boosting the market in the U.S. The market in Asia Pacific is projected to expand at a sluggish pace during the forecast period. Rising awareness regarding cancer, favorable government initiatives, advanced diagnosis laboratories with novel immunotherapies are driving the market in Asia Pacific. Increasing investment in research & development of immunotherapy and targeted therapies is creating a factor triggering the expansion of the market in Asia Pacific. Latin America and Middle East are projected to hold minimum share of the market due to late adoption of advanced technologies.

Request for TOC @

Major players operating in dendritic cell and CAR-T therapies market includes Novartis AG, Kite Pharma, Eureka Therapeutics, Fortress Biotech, Immune Therapeutics, Juno Therapeutics, Sorrento therapeutics, TILT Biotherapeutics, and Ziopharm.

# # #

Submitted by hawer on Thursday, 13 June 2019 at 9:09 PM
Category: Health Care & Medical
Related News

5 benefits of the diet on your health:
Saturday, 15 Jun 2019

Global H1N1 Vaccines Market Research Report 2019-2024
Saturday, 15 Jun 2019

MIGU Now Announces to Offer Hericium Erinaceus Extract for People to Stay Away from Alzheimer
Saturday, 15 Jun 2019

Bone Biology Market Market Scope and Opportunities Analysis 2017 – 2025
Saturday, 15 Jun 2019

Renal Cell Carcinoma Market Growth and Sales Forecast 2017 - 2025
Saturday, 15 Jun 2019

Related Events

ISPP 2019 - 12th International Symposium on Pedriatic Pain
Sunday, 16 Jun 2019

Predictive Analytics World for Healthcare - Las Vegas - June, 2019
Sunday, 16 Jun 2019

XXIV World Congress on Parkinson's Disease and Related Disorders, Montreal
Sunday, 16 Jun 2019

Radiology at Gleneagles, Scotland
Monday, 17 Jun 2019

25th Annual Update and Intensive Review of Internal Medicine, New York 2019
Monday, 17 Jun 2019

Latest News

Advantages of Buying Trout Fishing Flies
Monday, 17 Jun 2019

Fashion Jewelry - Customized Jewelry Just For You
Monday, 17 Jun 2019

Floryday Sheds more Light on Coupons and Points
Monday, 17 Jun 2019

Factors To Consider While Buying Property In Cyprus
Monday, 17 Jun 2019

Body Detox 101 Launches Its New Website To Talk About Latest Healthy Lifestyles Under One Umbrella
Sunday, 16 Jun 2019

Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2019
Today is Monday, 17 June 2019

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Consumer Technology
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
News & Media
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!

Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.

  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.

  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • ISPP 2019 - 12th International Symposium on Pedriatic Pain
  • The Perl Conference, Pittsburgh 2019
  • Predictive Analytics World for Business - Las Vegas - June, 2019
  • Deep Learning World Las Vegas 2019
  • Predictive Analytics World for Industry 4.0 - Las Vegas - June, 2019

  • Latest Jobs
    Sorry, there are currently no entries posted here.